Market Closed

BCYC
Bicycle Therapeutics plc
$ 3.37
-2.32%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago

Bicycle Therapeutics plc News

Latest Bicycle Therapeutics plc Stock News & BCYC Headlines

Bicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC) Stock Now Rated “Hold” by Wall Street Brokerages
24 days ago | defenseworld.net
Bicycle Therapeutics to Present Initial Duravelo-2 Data at 2026 ASCO Annual Meeting
6 months ago | businesswire.com
Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2026 Financial Results
7 months ago | businesswire.com
Bicycle Therapeutics Announces Oral and Poster Presentations at the 2026 ASCO Annual Meeting
7 months ago | businesswire.com
Bicycle Therapeutics Provides Update on Nuzefatide Pevedotin and EphA2 Pipeline at the AACR Annual Meeting 2026
7 months ago | businesswire.com
Wall Street Analysts Believe Bicycle Therapeutics (BCYC) Could Rally 137.88%: Here's is How to Trade
7 months ago | zacks.com
Bicycle Therapeutics (NASDAQ:BCYC) CEO Kevin Lee Sells 5,967 Shares
7 months ago | defenseworld.net
Bicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC) Receives Consensus Rating of “Hold” from Analysts
7 months ago | defenseworld.net
After Plunging 20.2% in 4 Weeks, Here's Why the Trend Might Reverse for Bicycle Therapeutics (BCYC)
8 months ago | zacks.com
Bicycle Therapeutics (BCYC) Loses 19.0% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
8 months ago | zacks.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

BCYC
Bicycle Therapeutics plc
$ 3.37
-2.32%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago